Page last updated: 2024-08-18

pyrroles and efavirenz

pyrroles has been researched along with efavirenz in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aberg, JA; Alston, BL; Brobst, SW; Fichtenbaum, CJ; Gerber, JG; Rosenkranz, SL; Segal, Y; Vega, JM; Yang, A	1
Daelemans, D; De Clercq, E; Huang, B; Kang, D; Liu, X; Pannecouque, C; Tian, Y; Zhan, P; Zhou, Z	1

Trials

1 trial(s) available for pyrroles and efavirenz

Article	Year
Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. Journal of acquired immune deficiency syndromes (1999), 2005, Jul-01, Volume: 39, Issue:3 Topics: Adult; Alkynes; Anti-HIV Agents; Atorvastatin; Benzoxazines; Cholesterol, LDL; Cyclopropanes; Drug Interactions; Female; Heptanoic Acids; HIV Infections; HIV Seronegativity; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Oxazines; Pravastatin; Pyrroles; Simvastatin	2005

Article

Year

Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study.

Journal of acquired immune deficiency syndromes (1999), 2005, Jul-01, Volume: 39, Issue:3

Topics: Adult; Alkynes; Anti-HIV Agents; Atorvastatin; Benzoxazines; Cholesterol, LDL; Cyclopropanes; Drug Interactions; Female; Heptanoic Acids; HIV Infections; HIV Seronegativity; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Oxazines; Pravastatin; Pyrroles; Simvastatin

2005

Other Studies

1 other study(ies) available for pyrroles and efavirenz

Article	Year
First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain. Bioorganic & medicinal chemistry letters, 2018, 05-01, Volume: 28, Issue:8 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cell Line, Tumor; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Humans; Hydrolysis; Mutation; Nevirapine; Nitriles; Prodrugs; Pyridazines; Pyrimidines; Pyrroles; Reverse Transcriptase Inhibitors	2018

Article

Year

First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain.

Bioorganic & medicinal chemistry letters, 2018, 05-01, Volume: 28, Issue:8

Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cell Line, Tumor; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Humans; Hydrolysis; Mutation; Nevirapine; Nitriles; Prodrugs; Pyridazines; Pyrimidines; Pyrroles; Reverse Transcriptase Inhibitors

2018